DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
6532
CAMPTOTHECIN-20-O-PROPIONATE
2
Small molecule
Investigational
Unknown
Unknown
Lymphoma; Neoplasms; Small Cell Lung Carcinoma
DNA topoisomerase I inhibitor
CAMPTOTHECIN-20-O-PROPIONATE
×
Maximum Phase:
2
First Approval:
None
UNII:
4S145C552U
Molecule Type:
Small molecule
Molecular Formula:
C23H20N2O5
Molecular Weight:
404.42
AlogP:
3.04
PSA:
87.49
HBD:
0.0
HBA:
#RotB:
3.0
Source:
LY-295501
2
Small molecule
Investigational
Unknown
Unknown
Fallopian Tube Neoplasms; Ovarian Neoplasms; Peritoneal Neoplasms
Unknown
LY-295501
×
Maximum Phase:
2
First Approval:
None
UNII:
240Y4YO0TN
Molecule Type:
Small molecule
Molecular Formula:
C15H12Cl2N2O4S
Molecular Weight:
387.24
AlogP:
3.44
PSA:
84.5
HBD:
2.0
HBA:
#RotB:
3.0
Source:
PALMIDROL
2
Small molecule
Investigational
Unknown
Unknown
Tourette Syndrome
Unknown
PALMIDROL
×
Maximum Phase:
2
First Approval:
None
UNII:
6R8T1UDM3V
Molecule Type:
Small molecule
Molecular Formula:
C18H37NO2
Molecular Weight:
299.5
AlogP:
4.58
PSA:
49.33
HBD:
2.0
HBA:
#RotB:
16.0
Source:
SARCOSINE
2
Small molecule
Investigational
Unknown
Unknown
Depressive Disorder, Major; Schizophrenia
Unknown
SARCOSINE
×
Maximum Phase:
2
First Approval:
None
UNII:
Z711V88R5F
Molecule Type:
Small molecule
Molecular Formula:
C3H7NO2
Molecular Weight:
89.09
AlogP:
-0.71
PSA:
49.33
HBD:
2.0
HBA:
#RotB:
2.0
Source:
GOLOTIMOD
2
Small molecule
Investigational
Unknown
Unknown
Hepatitis C, Chronic; Stomatitis
Unknown
GOLOTIMOD
×
Maximum Phase:
2
First Approval:
None
UNII:
637C487Y09
Molecule Type:
Small molecule
Molecular Formula:
C16H19N3O5
Molecular Weight:
333.34
AlogP:
0.47
PSA:
145.51
HBD:
5.0
HBA:
#RotB:
8.0
Source:
IOWH-032
2
Small molecule
Investigational
Unknown
Unknown
Digestive System Diseases
Unknown
IOWH-032
×
Maximum Phase:
2
First Approval:
None
UNII:
8Y3GDT6YWV
Molecule Type:
Small molecule
Molecular Formula:
C22H15Br2N3O4
Molecular Weight:
545.19
AlogP:
5.69
PSA:
97.48
HBD:
2.0
HBA:
#RotB:
6.0
Source:
BI 44370 TA
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
BI 44370 TA
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
(+)-EPICATECHIN
2
Small molecule
Investigational
Unknown
Unknown
Muscular Dystrophy, Duchenne; Prediabetic State; Friedreich Ataxia; Hypertension
Unknown
(+)-EPICATECHIN
×
Maximum Phase:
2
First Approval:
None
UNII:
LD6B6TT8Q5
Molecule Type:
Small molecule
Molecular Formula:
C15H14O6
Molecular Weight:
290.27
AlogP:
1.55
PSA:
110.38
HBD:
5.0
HBA:
#RotB:
1.0
Source:
CHOLESTEROL
2
Small molecule
Investigational
Unknown
Unknown
Asperger Syndrome; Autistic Disorder; Head and Neck Neoplasms; Porokeratosis; Smith-Lemli-Opitz Syndrome
Unknown
CHOLESTEROL
×
Maximum Phase:
2
First Approval:
None
UNII:
97C5T2UQ7J
Molecule Type:
Small molecule
Molecular Formula:
C27H46O
Molecular Weight:
386.66
AlogP:
7.39
PSA:
20.23
HBD:
1.0
HBA:
#RotB:
5.0
Source:
TNP-2092
2
Small molecule
Investigational
Unknown
Unknown
Infections; Gram-Positive Bacterial Infections
Bacterial DNA-directed RNA polymerase inhibitor
TNP-2092
×
Maximum Phase:
2
First Approval:
None
UNII:
W2P7EF7O6O
Molecule Type:
Small molecule
Molecular Formula:
C65H81FN6O15
Molecular Weight:
1205.39
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
PCI-27483
2
Small molecule
Investigational
Unknown
Unknown
Pancreatic Neoplasms
Coagulation factor VII inhibitor
PCI-27483
×
Maximum Phase:
2
First Approval:
None
UNII:
6073LCU8U9
Molecule Type:
Small molecule
Molecular Formula:
C26H24N6O9S
Molecular Weight:
596.58
AlogP:
0.83
PSA:
282.87
HBD:
9.0
HBA:
#RotB:
10.0
Source:
CYTOSINE
2
Small molecule
Investigational
Unknown
Unknown
Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Precursor Cell Lymphoblastic Leukemia-Lymphoma
Unknown
CYTOSINE
×
Maximum Phase:
2
First Approval:
None
UNII:
8J337D1HZY
Molecule Type:
Small molecule
Molecular Formula:
C4H5N3O
Molecular Weight:
111.1
AlogP:
-0.65
PSA:
71.77
HBD:
2.0
HBA:
#RotB:
0.0
Source:
PIROMELATINE
2
Small molecule
Investigational
Unknown
Unknown
Alzheimer Disease; Sleep Initiation and Maintenance Disorders
Melatonin receptor agonist
PIROMELATINE
×
Maximum Phase:
2
First Approval:
None
UNII:
S3UN2146K9
Molecule Type:
Small molecule
Molecular Formula:
C17H16N2O4
Molecular Weight:
312.33
AlogP:
2.1
PSA:
84.33
HBD:
2.0
HBA:
#RotB:
5.0
Source:
SABARUBICIN
2
Small molecule
Investigational
Unknown
Unknown
Neoplasms; Testicular Neoplasms; Prostatic Neoplasms, Castration-Resistant
Unknown
SABARUBICIN
×
Maximum Phase:
2
First Approval:
None
UNII:
XS499WOZ93
Molecule Type:
Small molecule
Molecular Formula:
C32H37NO13
Molecular Weight:
643.64
AlogP:
-0.13
PSA:
235.53
HBD:
7.0
HBA:
#RotB:
6.0
Source:
L 756423
2
Small molecule
Investigational
Unknown
Unknown
HIV Infections
Unknown
L 756423
×
Maximum Phase:
2
First Approval:
None
UNII:
862SGU1BRL
Molecule Type:
Small molecule
Molecular Formula:
C39H48N4O5
Molecular Weight:
652.84
AlogP:
4.22
PSA:
118.28
HBD:
4.0
HBA:
#RotB:
11.0
Source:
DERSALAZINE
2
Small molecule
Investigational
Unknown
Unknown
Colitis, Ulcerative
Unknown
DERSALAZINE
×
Maximum Phase:
2
First Approval:
None
UNII:
WS1IH75AJT
Molecule Type:
Small molecule
Molecular Formula:
C36H33N5O4
Molecular Weight:
599.69
AlogP:
7.53
PSA:
120.38
HBD:
2.0
HBA:
#RotB:
8.0
Source:
DELEOBUVIR SODIUM
2
Small molecule
Investigational
Unknown
Unknown
Hepatitis C, Chronic
Unknown
DELEOBUVIR SODIUM
×
Maximum Phase:
2
First Approval:
None
UNII:
6X4T3L6431
Molecule Type:
Small molecule
Molecular Formula:
C34H32BrN6NaO3
Molecular Weight:
675.56
AlogP:
6.85
PSA:
114.93
HBD:
2.0
HBA:
#RotB:
7.0
Source:
BRILANESTRANT
2
Small molecule
Investigational
Unknown
Unknown
Breast Neoplasms
Estrogen receptor alpha antagonist
BRILANESTRANT
×
Maximum Phase:
2
First Approval:
None
UNII:
9MM2R1A06R
Molecule Type:
Small molecule
Molecular Formula:
C26H20ClFN2O2
Molecular Weight:
446.91
AlogP:
6.82
PSA:
65.98
HBD:
2.0
HBA:
#RotB:
6.0
Source:
ENCLOMIPHENE
2
Small molecule
Investigational
Unknown
Unknown
Hypogonadism; Obesity
Estrogen receptor alpha modulator
ENCLOMIPHENE
×
Maximum Phase:
2
First Approval:
None
UNII:
R6D2UI4FLS
Molecule Type:
Small molecule
Molecular Formula:
C26H28ClNO
Molecular Weight:
405.97
AlogP:
6.56
PSA:
12.47
HBD:
0.0
HBA:
#RotB:
9.0
Source:
LARSUCOSTEROL
2
Small molecule
Investigational
Unknown
Unknown
Cholangitis, Sclerosing; Hepatitis, Alcoholic; Severe Acute Respiratory Syndrome
Unknown
LARSUCOSTEROL
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C27H46O5S
Molecular Weight:
482.73
AlogP:
6.33
PSA:
83.83
HBD:
2.0
HBA:
#RotB:
7.0
Source:
TOREFORANT
2
Small molecule
Investigational
Unknown
Unknown
Arthritis, Rheumatoid
Histamine H4 receptor antagonist
TOREFORANT
×
Maximum Phase:
2
First Approval:
None
UNII:
U6LA7G393X
Molecule Type:
Small molecule
Molecular Formula:
C23H32N6
Molecular Weight:
392.55
AlogP:
4.48
PSA:
69.73
HBD:
2.0
HBA:
#RotB:
6.0
Source:
AVAGACESTAT
2
Small molecule
Investigational
Unknown
Unknown
Alzheimer Disease
Gamma-secretase inhibitor
AVAGACESTAT
×
Maximum Phase:
2
First Approval:
None
UNII:
TQ44WWY45Q
Molecule Type:
Small molecule
Molecular Formula:
C20H17ClF4N4O4S
Molecular Weight:
520.89
AlogP:
3.92
PSA:
119.39
HBD:
1.0
HBA:
#RotB:
9.0
Source:
PILARALISIB
2
Small molecule
Investigational
Unknown
Unknown
Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Glioblastoma; Lymphoma; Neoplasms; Endometrial Neoplasms
PI3-kinase class I inhibitor
PILARALISIB
×
Maximum Phase:
2
First Approval:
None
UNII:
60ES45KTMK
Molecule Type:
Small molecule
Molecular Formula:
C25H25ClN6O4S
Molecular Weight:
541.03
AlogP:
4.51
PSA:
148.33
HBD:
4.0
HBA:
#RotB:
8.0
Source:
AMMONIUM TRICHLOROTELLURATE
2
Small molecule
Investigational
Unknown
Unknown
Macular Degeneration; Alopecia; Condylomata Acuminata; Dermatitis, Atopic; Leukemia, Myeloid, Acute; Myelodysplastic Syndromes; Psoriasis
Unknown
AMMONIUM TRICHLOROTELLURATE
×
Maximum Phase:
2
First Approval:
None
UNII:
708681952A
Molecule Type:
Small molecule
Molecular Formula:
C2H8Cl3NO2Te
Molecular Weight:
312.05
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
BMS-646256
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
BMS-646256
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ROLIPRAM
2
Small molecule
Investigational
Unknown
Unknown
Depressive Disorder, Major; Huntington Disease; Nervous System Diseases; Multiple Sclerosis
Unknown
ROLIPRAM
×
Maximum Phase:
2
First Approval:
None
UNII:
K676NL63N7
Molecule Type:
Small molecule
Molecular Formula:
C16H21NO3
Molecular Weight:
275.35
AlogP:
2.62
PSA:
47.56
HBD:
1.0
HBA:
#RotB:
4.0
Source:
SAR-113945
2
Small molecule
Investigational
Unknown
Unknown
Osteoarthritis
Inhibitor of nuclear factor kappa B kinase beta subunit inhibitor
SAR-113945
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LT-NS001
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
LT-NS001
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TOFIMILAST
2
Small molecule
Investigational
Unknown
Unknown
Asthma; Pulmonary Disease, Chronic Obstructive
Phosphodiesterase 4 inhibitor
TOFIMILAST
×
Maximum Phase:
2
First Approval:
None
UNII:
5D7022962A
Molecule Type:
Small molecule
Molecular Formula:
C18H21N5S
Molecular Weight:
339.47
AlogP:
4.1
PSA:
48.53
HBD:
0.0
HBA:
#RotB:
3.0
Source:
LOMETREXOL
2
Small molecule
Investigational
Unknown
Unknown
Neoplasms; Lung Neoplasms
Unknown
LOMETREXOL
×
Maximum Phase:
2
First Approval:
None
UNII:
6P3AVY8A7Q
Molecule Type:
Small molecule
Molecular Formula:
C21H25N5O6
Molecular Weight:
443.46
AlogP:
0.62
PSA:
187.5
HBD:
6.0
HBA:
#RotB:
9.0
Source:
AZD6765
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
AZD6765
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CIPARGAMIN
2
Small molecule
Investigational
Unknown
Unknown
Malaria, Falciparum; Malaria
P-type ATPase inhibitor
CIPARGAMIN
×
Maximum Phase:
2
First Approval:
None
UNII:
Z7Q4FWA04P
Molecule Type:
Small molecule
Molecular Formula:
C19H14Cl2FN3O
Molecular Weight:
390.25
AlogP:
4.34
PSA:
56.92
HBD:
3.0
HBA:
#RotB:
0.0
Source:
INO-1001
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
INO-1001
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CENERIMOD
2
Small molecule
Investigational
Unknown
Unknown
Liver Diseases; Lupus Erythematosus, Systemic
Sphingosine 1-phosphate receptor Edg-1 modulator
CENERIMOD
×
Maximum Phase:
2
First Approval:
None
UNII:
Y333RS1786
Molecule Type:
Small molecule
Molecular Formula:
C25H31N3O5
Molecular Weight:
453.54
AlogP:
4.07
PSA:
110.73
HBD:
2.0
HBA:
#RotB:
9.0
Source:
TIRABRUTINIB
2
Small molecule
Investigational
Unknown
Unknown
Arthritis, Rheumatoid; Neoplasms; Leukemia, Lymphocytic, Chronic, B-Cell; Sjogren's Syndrome; Urticaria
Tyrosine-protein kinase BTK inhibitor
TIRABRUTINIB
×
Maximum Phase:
2
First Approval:
None
UNII:
LXG44NDL2T
Molecule Type:
Small molecule
Molecular Formula:
C25H22N6O3
Molecular Weight:
454.49
AlogP:
2.75
PSA:
108.27
HBD:
1.0
HBA:
#RotB:
4.0
Source:
1
2
…
103
104
105
106
107
108
109
…
186
187
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA